ALADIN: wish granted in inherited polycystic kidney disease?
- PMID: 23972262
- PMCID: PMC4054814
- DOI: 10.1016/S0140-6736(13)61541-X
ALADIN: wish granted in inherited polycystic kidney disease?
Figures
Comment on
-
Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial.Lancet. 2013 Nov 2;382(9903):1485-95. doi: 10.1016/S0140-6736(13)61407-5. Epub 2013 Aug 21. Lancet. 2013. PMID: 23972263 Clinical Trial.
References
-
- Torres VE, Harris PC, Pirson Y. Autosomal dominant polycystic kidney disease. Lancet. 2007;369:1287–301. - PubMed
-
- Yamaguchi T, Nagao S, Wallace DP, et al. Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys. Kidney Int. 2003;63:1983–94. - PubMed
-
- Praetorius HA, Spring KR. Bending the MDCK cell primary cilium increases intracellular calcium. J Membr Biol. 2001;184:71–79. - PubMed
-
- Reisine T, Bell GI. Molecular properties of somatostatin receptors. Neuroscience. 1995;67:777–90. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical